(Drug Name) (Drug Form) (Drug Strength)
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Afrezza: Inhalation powder (4-8U)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Afrezza 4u(30)-8u(60) Pwd Inh
Drug Image file default-drug-image.png
Afrezza 4u(60)-8u(30) Pwd Inh
Drug Image file default-drug-image.png
Afrezza 4u(30)-8u(60) Pwd Inh
Drug Image file default-drug-image.png
Afrezza 4u(60)-8u(30) Pwd Inh
Drug Image file default-drug-image.png
Afrezza 4u(90)-8u(90) Pwd Inh

What is this Medicine?

INSULIN (IN su lin) is a human-made form of insulin. This medicine lowers the amount of sugar in your blood. It is a short-acting insulin that starts working about 15 minutes after it is inhaled.

CVS Pharmacy Patient Statistics for Afrezza: Inhalation powder(4-8U)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Afrezza 4unit(30)-8unit(60) Powder for Inhalation

NDC: 000245882
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus

Storage Information
Store opened (in use) product at room temperature (below 86 degrees F) for up to 10 days
Store unopened containers in refrigerator (36 to 46 degrees F)
Unrefrigerated product must be used within 10 days or be discarded
Afrezza 4unit(30)-8unit(60) Powder for Inhalation
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Afrezza

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.